CoV-GLUEGenomeCountriesLineagesMutationsInsertionsDeletionsUpdated:

CoV-GLUE | Mutations | Mutation

CoV-GLUE Mutation: ORF = M : CodonNum = 2 & Codon = ---

Details of the codons used for the mutation across all lineages (CodonProp is the proportion each codon is used for this AA mutation):

ORFCodonNumMutORF1abMutMutTypeRefCodonMutCodonAACountCodonCountCodonPropGenome Position
M2A2deldelGCA---4646126526-26528

Details of the mutation no within lineages (LineageCodonProp is the proportion the codon is observed at, at this particular site, on each lineage):

ORFCodonNumMutRefCodonMutCodonCodonCountAACountLineageLineageCodonProp
M2A2delGCA---4646All0.000009
M2A2delGCA---66B.10.000055
M2A2delGCA---66B.1.1.70.000005
M2A2delGCA---44AY.40.000006
M2A2delGCA---220.111111
M2A2delGCA---22AY.4.50.000215
M2A2delGCA---22AY.430.000009
M2A2delGCA---22AY.46.60.000144
M2A2delGCA---22B.1.617.20.000008
M2A2delGCA---22P.10.000032
M2A2delGCA---11AY.1000.000046
M2A2delGCA---11AY.1080.001103
M2A2delGCA---11AY.1180.000063
M2A2delGCA---11AY.1200.000037
M2A2delGCA---11AY.250.000006
M2A2delGCA---11AY.440.000006
M2A2delGCA---11AY.46.20.000635
M2A2delGCA---11AY.680.000274
M2A2delGCA---11AY.90.000068
M2A2delGCA---11B.1.1.1390.022727
M2A2delGCA---11B.1.1.2880.001916
M2A2delGCA---11B.1.1390.000733
M2A2delGCA---11B.1.1770.000013
M2A2delGCA---11B.1.177.160.000664
M2A2delGCA---11B.1.177.170.000821
M2A2delGCA---11B.1.177.870.000728
M2A2delGCA---11B.1.5610.000397
M2A2delGCA---11P.1.150.000232

CoV-GLUE is still in development. CoV-GLUE was originally developed as part of COG-UK by Josh Singer using the GLUE framework at the MRC-University of Glasgow Centre for Virus Research (CVR). In 2021 it was redeveloped by Richard Orton to scale to the millions of genome sequences available. We acknowledge support from the MRC (MC_UU_12014/12), WT (220977/Z/20/Z) and UKRI G2P (MR/W005611/1). Please contact Richard Orton with any queries: Richard.Orton@glasgow.ac.uk

CoV-GLUE uses sequence data from GISAID. GISAID data provided via this web application is subject to GISAID's Terms and Conditions.